SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 214 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $11,000 | -99.8% | 421 | -99.8% | 0.00% | -99.7% |
| Q3 2016 | $6,048,000 | +18.8% | 244,550 | -2.2% | 0.39% | +10.5% |
| Q2 2016 | $5,093,000 | +67.0% | 250,000 | +25.0% | 0.35% | +31.7% |
| Q1 2016 | $3,050,000 | +821.5% | 200,000 | +927.2% | 0.27% | +1240.0% |
| Q2 2015 | $331,000 | +78.9% | 19,470 | -12.6% | 0.02% | +25.0% |
| Q4 2014 | $185,000 | – | 22,285 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |